ConforMIS, Inc. (CFMS) Stake Maintained by Alliancebernstein L.P.
Alliancebernstein L.P. continued to hold its position in ConforMIS, Inc. (NASDAQ:CFMS) during the first quarter, Holdings Channel reports. The firm owned 30,500 shares of the medical instruments supplier’s stock at the end of the first quarter. Alliancebernstein L.P.’s holdings in ConforMIS were worth $159,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. American International Group Inc. increased its position in ConforMIS by 7.0% in the first quarter. American International Group Inc. now owns 22,009 shares of the medical instruments supplier’s stock worth $115,000 after buying an additional 1,448 shares during the last quarter. Stonebridge Capital Management Inc. purchased a new position in ConforMIS during the first quarter worth about $220,000. Creative Planning purchased a new position in ConforMIS during the first quarter worth about $236,000. Wells Fargo & Company MN increased its position in ConforMIS by 1.8% in the first quarter. Wells Fargo & Company MN now owns 53,930 shares of the medical instruments supplier’s stock worth $282,000 after buying an additional 935 shares during the last quarter. Finally, Teachers Advisors LLC increased its position in ConforMIS by 27.6% in the fourth quarter. Teachers Advisors LLC now owns 73,565 shares of the medical instruments supplier’s stock worth $596,000 after buying an additional 15,890 shares during the last quarter. Institutional investors and hedge funds own 38.58% of the company’s stock.
ConforMIS, Inc. (CFMS) traded up 2.06% during mid-day trading on Friday, reaching $3.47. The company had a trading volume of 164,158 shares. The company’s 50-day moving average is $4.25 and its 200-day moving average is $5.05. The stock’s market capitalization is $155.58 million. ConforMIS, Inc. has a one year low of $3.22 and a one year high of $10.93.
ConforMIS (NASDAQ:CFMS) last released its earnings results on Thursday, August 3rd. The medical instruments supplier reported ($0.28) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.36) by $0.08. The company had revenue of $18.50 million during the quarter, compared to analyst estimates of $19.34 million. ConforMIS had a negative return on equity of 66.61% and a negative net margin of 72.87%. ConforMIS’s quarterly revenue was down 4.1% on a year-over-year basis. During the same period in the prior year, the company posted ($0.34) earnings per share. Equities research analysts anticipate that ConforMIS, Inc. will post ($1.30) earnings per share for the current year.
COPYRIGHT VIOLATION NOTICE: “ConforMIS, Inc. (CFMS) Stake Maintained by Alliancebernstein L.P.” was first posted by Watch List News and is owned by of Watch List News. If you are viewing this article on another website, it was copied illegally and reposted in violation of United States and international copyright laws. The correct version of this article can be accessed at https://www.watchlistnews.com/conformis-inc-cfms-stake-maintained-by-alliancebernstein-l-p/1508056.html.
Several research analysts recently commented on CFMS shares. B. Riley reissued a “buy” rating and set a $7.50 price target on shares of ConforMIS in a research report on Thursday, May 11th. Oppenheimer Holdings, Inc. set a $6.00 price target on ConforMIS and gave the company a “buy” rating in a research report on Friday, August 4th. Canaccord Genuity reduced their price target on ConforMIS from $8.00 to $6.00 and set a “hold” rating for the company in a research report on Friday, August 4th. BTIG Research started coverage on ConforMIS in a research report on Tuesday, June 20th. They set a “neutral” rating for the company. Finally, Deutsche Bank AG reissued a “hold” rating and set a $5.00 price target (down from $6.00) on shares of ConforMIS in a research report on Friday, August 4th. Four investment analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus price target of $7.75.
In other news, Director Bradley Langdale sold 6,722 shares of the company’s stock in a transaction that occurred on Tuesday, June 20th. The stock was sold at an average price of $4.30, for a total value of $28,904.60. Following the completion of the transaction, the director now directly owns 26,533 shares of the company’s stock, valued at $114,091.90. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 9.55% of the company’s stock.
ConforMIS Company Profile
ConforMIS, Inc is a medical technology company. The Company uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants, which are individually sized and shaped, to fit each patient’s anatomy. The Company’s iFit technology platform is applicable to various joints.
Want to see what other hedge funds are holding CFMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ConforMIS, Inc. (NASDAQ:CFMS).
Receive News & Ratings for ConforMIS Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConforMIS Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.